Integrative Neurology With LaFaver & Subramanian

• Parkinson's Disease Highlights 2023   Neurologists Kathrin LaFaver and Alberto Espay review the top Parkinson's disease research in 2023, including biomarkers and what the data on GLP-1 receptor agonists may mean for future research.
  Medscape Neurology, December 15, 2023
  2
• Is Most Parkinson's Disease Man-Made?   Indu Subramanian interviews Ray Dorsey about the link between environmental toxins and Parkinson's disease and his advocacy work to end this disease.
  Medscape Neurology, November 20, 2023
  27
• What to Tell Your Patients About Anti-amyloids for Alzheimer's Disease   Kathrin LaFaver and Meredith Wicklund discuss indications and contraindications for lecanemab and other anti-amyloids for Alzheimer's disease that may be coming soon.
  Medscape Neurology, November 13, 2023
  2
• Highlights From the 2023 Movement Disorder Congress   Neurologists Kathrin LaFaver and Indu Subramanian discuss highlights from the 2023 International Congress of Parkinson's Disease and Movement Disorders.
  Medscape Neurology, October 13, 2023
• Diet and Brain: From Processed Foods to the Farmers Market   Kathrin LaFaver interviews fellow neurologist Madhureeta Achari on the nutritional deficiencies she checks for and why she invites her patients to the farmers market.
  Medscape Neurology, August 31, 2023
  10
• 2023 World Parkinson Congress Highlights   Neurologists Kathrin LaFaver and Indu Subramanian discuss updates from the 2023 World Parkinson Congress and how the multidisciplinary approach is key.
  Medscape Neurology, August 07, 2023
  1
• Roll Your Eyes at 'Wellness'? So Did This Wellness Officer   Indu Subramanian speaks with neurologist-turned-wellness officer Jennifer Bickel about how to really tackle physician burnout and the stigma of mental health.
  Medscape Neurology, July 10, 2023
  1
• What the PD Biomarker Breakthrough Means in Practice   Neurologists Indu Subramanian and Michael Okun discuss the implications of the alpha-synuclein seed amplification assay for the diagnosis and management of Parkinson's disease.
  Medscape Neurology, June 21, 2023
  1
• Can Artificial Intelligence Help Diagnose Dementia?   Kathrin LaFaver interviews David Jones about how artificial intelligence could help in dementia and Alzheimer's diagnosis and management.
  Medscape Neurology, June 12, 2023
  6
• Top 5 Movement Disorders Highlights From AAN 2023   Kathrin LaFaver discusses the movement disorders presentations that piqued her interest at the 2023 American Academy of Neurology meeting with fellow neurologist Indu Subramanian.
  Medscape Neurology, May 17, 2023
  1
• General Neurology Needs Recruits and Respect   Kathrin LaFaver, MD interviews Louise M. Klebanoff, MD, about her recent viewpoint on why modern neurology fails outpatients and the importance of generalists.
  Medscape Neurology, April 24, 2023
• Parkinson's Disease: What's Trauma Got to Do With It?   Kathrin LaFaver interviews fellow neurologist Indu Subramanian about her paper on childhood trauma and Parkinson's disease and the broader data on trauma-informed neurology care.
  Medscape Neurology, March 31, 2023
  1
• What Is Contemplative Medicine?   Indu Subramanian tells Kathrin LaFaver about the fellowship she did in contemplative medicine and how to integrate mindfulness into work and life.
  Medscape Neurology, November 16, 2022
  2
• Wellness as Therapy for Parkinson's Disease   Kathrin LaFaver, MD, and Indu Subramanian, MD, discuss achievements and goals of the wellness task force of the Movement Disorder Society.
  Medscape Neurology, October 24, 2022
• Will Parkinson's Disease Therapy Move Past Carbidopa-Levodopa?   Kathrin LaFaver, MD, and Indu Subramanian, MD, discuss updates on Parkinson's disease, including highlights of the 2022 International Congress of Parkinson's Disease and Movement Disorders.
  Medscape Neurology, October 13, 2022
  2
• Why Neurologists Should Care About Reproductive Rights   Many neurologic conditions require treatment with teratogenic agents. Abortion bans complicate these treatment decisions.
  Medscape Neurology, September 26, 2022
  3
• A Novel Treatment and Other Parkinson's Updates From AAN 2022   Dr Kathrin LaFaver and Dr Indu Subramanian discuss promising data with the GLP-1 agonist liraglutide, and other research on Parkinson's disease that caught their attention.
  Medscape Neurology, August 17, 2022
  4
• An Overlooked Factor in Neurologic Disease   Dr Kathrin LaFaver speaks with Dr Indu Subramanian about an approach for addressing loneliness in this vulnerable population.
  Medscape Neurology, June 28, 2022
  2
• Assessing and Managing Functional Neurologic Disorders   Drs Subramanian, LaFaver, and Perez discuss the need for more education on functional movement disorders, a new society devoted to these conditions, and the rise of "TikTok tics" during COVID.
  Medscape Neurology, June 16, 2022
  9
• The Latest in Movement Disorder Research   This year's AAN meeting highlighted differences in outcomes based on patients' backgrounds.
  Medscape Neurology, May 19, 2022
  1